Regal Rexnord enters the week with an unusual split personality: the stock is up 13% over the past month and attracting a fresh wave of analyst upgrades, yet short sellers have been quietly rebuilding positions at the fastest pace in months.
The short interest story is the most striking tension in the data right now. Bearish positioning has risen 31% over the past 30 days, reaching 5% of the free float — a level that puts RRX in genuinely contested territory. The week-on-week jump of 12.5% is particularly notable: shorts added meaningfully even as the stock climbed. Cost to borrow has moved with it, rising 21% on the week to 0.58%, and up 67% over the past month. That said, the borrow market remains far from stressed — availability stands at roughly 1,330% of outstanding short interest, meaning the lending pool is deep and new shorts face no meaningful friction entering positions. This looks more like deliberate conviction building than a forced technical move.
Options positioning offers no strong signal either way. The put/call ratio is virtually flat against its 20-day average, at 0.92 versus a mean of 0.93, and the z-score is negligible. A month ago, during the mid-May dip, PCR briefly spiked above 1.10 — a defensive pulse that has since fully unwound. With the 52-week range running from 0.01 to 1.33, the current reading is squarely neutral. Options traders are not hedging aggressively into the rally, nor are they reaching for upside calls. The positioning looks balanced rather than charged.
The Street, by contrast, is decidedly constructive. DA Davidson initiated coverage with a Buy and a $260 target yesterday — the freshest signal from the analyst community. JP Morgan raised its target to $240 last month while maintaining Overweight. Keybanc sits at $265. The consensus is a clean Buy across eight ratings, with a mean target of $252, implying roughly 13% further upside from the current $222.53. Forward earnings revisions have been strong — RRX ranks in the 83rd percentile for 12-month forward EPS growth — and the analyst recommendation differential score is at the 93rd percentile, signalling the Street is more bullish on this name than almost any comparable stock in the universe. The EV/EBITDA of 13.1x and P/E of 18.6x have both expanded over the past month as the stock has re-rated higher, so the valuation argument is less compelling than it was heading into Q1 results.
Those Q1 results are worth noting for context. The earnings history shows two consecutive prints in early May where the stock fell roughly 7% the following day and extended losses to around 10% over the following week. Both events appear to be the same earnings release (May 6-7), suggesting a single sharp post-results drop that ran into the subsequent week. The prior print, in February, delivered an 8.9% gain on the day. The next earnings date is July 31 — close enough that the rebuilding short position may partly reflect traders positioning ahead of that event, given the recent track record of post-earnings weakness.
Institutional ownership adds one more layer of interest. BNY Asset Management reported a new position of nearly 947,000 shares as of June 1, and Wellington Management added 884,000 shares in the same filing window. Both are meaningful moves for a company of this size. On the insider side, the CEO sold shares across multiple transactions in May totalling roughly $3.3 million, and the CFO sold $1.3 million worth on May 22 — a cluster of executive selling into the rally that warrants watching, even if routine tax-planning explanations often apply.
The setup heading into July 31 is therefore less about whether the Street is on board — it clearly is — and more about whether the rebuilding short base proves prescient again after a third consecutive earnings print.
See the live data behind this article on ORTEX.
Open RRX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
